Cardiovascular Medicine Research
Overarching Strategic Theme
The research and academic aspects of our clinical programs are being developed in close connection and alignment to the development of their clinical/patient care aspects. This parallel development is mutually beneficial both to the research potential and the clinical/patient care potential. One feeds positively to the other in a full circle configuration.
We have a long history of building clinical programs of excellence to better treat our own patients and at the same time advance a whole clinical field bringing benefits to patients beyond the boundaries of our institution and state. Some of those include:
- Long QT Legend: Revolutionized Arrhythmia World and Pharma World
- Defined Role of EP Studies and EKG Holter in Arrhythmias
- Beta-Blocker 'Revolution' in HF
- Defined Myocarditis Diagnosis & Therapy
- Gene Discoveries: Cardiomyopathies, HHT, Supravalvular Stenosis and many others
- Pioneering Mechanical Circulatory Support: IABP Development ('60s–'70s) + First Total Artificial Heart ('60s–'80s) + Continued Driver of Innovation in the field (Read More.)
- U.T.A.H. Cardiac Transplant Program: Driving Innovation since 1985 + one of handful programs worldwide > 1500 transplants
- Antibody Mediated Rejection (AMR) Legend in Heart Transplantation
Utah's Innovations & Contributions to the Cardiovascular Field
History Keeps Repeating Itself!
More to come! On-going innovative work in several CV fields. Join us!
Current Research Opportunities
For current research opportunities, please contact:
Stavros Drakos, MD, PhD (Stavros.Drakos@hsc.utah.edu), Director of Cardiovascular Research or
John Kirk, MBA, CCRP (John.Kirk@hsc.utah.edu), Cardiovascular Research Manager